Investigator-initiated Clinical Trial of MIKE-1

NCT05064618 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Am80
DRUG: Gemcitabine
DRUG: nab-Paclitaxel

Sponsor

Nagoya University

Collaborators

[object Object]